Login / Signup

Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance.

Viktoria MelcherMonika GrafMarta InterlandiNatalia MorenoFlavia W de FariaSu Na KimDennis KastratiSonja KorbankaAmelie AlfertJoachim GerßGerd Meyer Zu HörsteWolfgang HartmannMichael C FrühwaldMartin DugasUlrich SchüllerMartin HasselblattThomas K AlbertKornelius Kerl
Published in: Acta neuropathologica (2019)
Atypical teratoid/rhabdoid tumors (ATRT) are known for their heterogeneity concerning pathophysiology and outcome. However, predictive factors within distinct subgroups still need to be uncovered. Using multiplex immunofluorescent staining and single-cell RNA sequencing we unraveled distinct compositions of the immunological tumor microenvironment (TME) across ATRT subgroups. CD68+ cells predominantly infiltrate ATRT-SHH and ATRT-MYC and are a negative prognostic factor for patients' survival. Within the murine ATRT-MYC and ATRT-SHH TME, Cd68+ macrophages are core to intercellular communication with tumor cells. In ATRT-MYC distinct tumor cell phenotypes express macrophage marker genes. These cells are involved in the acquisition of chemotherapy resistance in our relapse xenograft mouse model. In conclusion, the tumor cell-macrophage interaction contributes to ATRT-MYC heterogeneity and potentially to tumor recurrence.
Keyphrases